With the implementation of Donald Trump’s tariffs on India scheduled for next month, many Americans may experience increased medical expenses, especially concerning prescription medications, according to a report by BBC. These tariffs, set to take effect on April 2, are a response to India’s own taxation on American products. Despite India’s attempts at reconciliation, including an unplanned visit from Commerce Minister Piyush Goyal, Trump appears to be resistant to these overtures. A major concern for the United States revolves around the potential impact on generic drugs produced in India, which constitute approximately 90% of prescriptions in the country and contribute to significant savings in healthcare costs, amounting to $219 billion in 2022, as reported by BBC. Experts caution that without a resolution, the affordability of certain Indian generics may decline, leading to possible shortages. Over 60% of prescriptions for various conditions, including hypertension and mental health issues, depend on Indian-manufactured medications, with sertraline, a common antidepressant, exemplifying this reliance. These generics are often much more affordable than their branded equivalents.
The tariffs imposed by Trump are already influencing the costs of raw materials for drug production, exacerbated by increased tariffs on imports from China. While major pharmaceutical companies like Pfizer are relocating some of their manufacturing operations to the United States, smaller generic manufacturers may face significant challenges. Sudarshan Jain from the Indian Pharmaceutical Association highlighted that production costs in India are at least three to four times lower than in the US. The IPA, representing India’s largest pharmaceutical companies, has proposed eliminating duties on US drug exports to mitigate the adverse effects of reciprocal tariffs. In a recent budget move, Prime Minister Narendra Modi’s government exempted 36 life-saving medications from basic customs duties, prompting Trump to assert that India was conceding to his demands.
